首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >From the Cover: A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization
【2h】

From the Cover: A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization

机译:从封面:二硫键的氧化还原酶样蛋白(DsbA-L)调节脂联素的多聚化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Impairments in adiponectin multimerization lead to defects in adiponectin secretion and function and are associated with diabetes, yet the underlying mechanisms remain largely unknown. We have identified an adiponectin-interacting protein, previously named GST-kappa, by yeast 2-hybrid screening. The adiponectin-interacting protein contains 2 thioredoxin domains and has very little sequence similarity to other GST isoforms. However, this protein shares high sequence and secondary structure homology to bacterial disulfide-bond A oxidoreductase (DsbA) and is thus renamed DsbA-like protein (DsbA-L). DsbA-L is highly expressed in adipose tissue, and its expression level is negatively correlated with obesity in mice and humans. DsbA-L expression in 3T3-L1 adipocytes is stimulated by the insulin sensitizer rosiglitazone and inhibited by the inflammatory cytokine TNFα. Overexpression of DsbA-L promoted adiponectin multimerization while suppressing DsbA-L expression by RNAi markedly and selectively reduced adiponectin levels and secretion in 3T3-L1 adipocytes. Our results identify DsbA-L as a key regulator for adiponectin biosynthesis and uncover a potential new target for developing therapeutic drugs for the treatment of insulin resistance and its associated metabolic disorders.
机译:脂联素多聚体的损伤导致脂联素分泌和功能的缺陷,并与糖尿病有关,但是其潜在机制仍是未知的。我们已经通过酵母2杂交筛选鉴定了与脂联素相互作用的蛋白,以前称为GST-kappa。脂联素相互作用蛋白含有2个硫氧还蛋白结构域,与其他GST同工型的序列相似性很小。但是,该蛋白质与细菌二硫键A氧化还原酶(DsbA)具有高度的序列和二级结构同源性,因此被重命名为DsbA样蛋白质(DsbA-L)。 DsbA-L在脂肪组织中高度表达,其表达水平与小鼠和人类肥胖呈负相关。胰岛素敏化剂罗格列酮刺激3T3-L1脂肪细胞中的DsbA-L表达,而炎性细胞因子TNFα抑制DsbA-L表达。 DsbA-L的过表达促进脂联素多聚,同时通过RNAi显着抑制DsbA-L的表达,并选择性降低3T3-L1脂肪细胞中脂联素的水平和分泌。我们的研究结果确定DsbA-L是脂联素生物合成的关键调节剂,并发现了开发治疗胰岛素抵抗及其相关代谢异常的治疗药物的潜在新目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号